On-body Injector Patient Instructions for Use:

Which version of the Instructions for Use did your doctors's office give you?

If you don’t recognize the images above or if you prefer a physical copy, contact your doctor.

Onpro® Kit HCP Instructions for Use:

Which version of the Instructions for Use came with your patient's on-body injector?

Indication

Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the... Read More

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to return to the consumer site, please click CANCEL.

The majority of commercial and Medicare plans cover Neulasta® and Neulasta® Onpro®

Most prescriptions cost $5 or less out of pocket per dose of Neulasta®

For more information on paying for Neulasta® Onpro®, find your insurance type below.

Amgen is committed to help ensure you will be able to get Neulasta® Onpro® at an affordable cost.

The list price for Neulasta® is $6231* per dose. Neulasta® is a single dose administered once per chemotherapy cycle. Most patients do not pay the list price. Your actual cost will vary. Talk to your insurance provider.

*List price is also referred to as wholesale acquisition cost or WAC. WAC is the price at which Amgen sells its products to wholesalers.

The guide below will help you get a better idea of what you may expect to pay

I have commercial insurance

(eg, self-purchased or through an employer)

plus-img minus-img

Most prescriptions cost $5 or less out of pocket per dose of Neulasta®

85 percent

85% of prescriptions for Neulasta® for patients with commercial insurance cost $5 or less per dose*

The remaining 15% of Neulasta® prescriptions cost patients an average of $697 per dose*

*These data are based on paid claims data from national data providers for the period 1/1/2018–12/31/2018. Your actual cost may vary depending on your dose, insurance coverage, and eligibility for support programs. Talk to your insurance provider for specific information about your prescription coverage.


Amgen FIRST STEP™

For eligible commercially insured patients

If you are an eligible commercially insured
patient, Amgen FIRST STEP™ can help cover your
out-of-pocket prescription costs including
deductible, co-insurance, and co-payment.

Visit Amgen FIRST STEP™ Now
first step 1

$0 out-of-pocket for the
first dose or cycle

first step 2

$5 out-of-pocket for
subsequent doses or cycles,
up to the brand program
benefit maximum

first step 3

No income eligibility
requirement

Visit Amgen FIRST STEP™ Now

Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal, state, or government-funded healthcare program. Not valid where prohibited by law.

I am on Medicare

plus-img minus-img

Traditional Medicare (Part B)

46 percent

46% of prescriptions for Neulasta® for patients with Medicare Part B insurance cost $5 or less per dose*

The remaining 54% of Neulasta® prescriptions cost patients an average of $908 per dose*

Patients with traditional Medicare (Part B) may also carry supplemental insurance, such as Medigap. 99% of prescriptions for Neulasta® for patients with Medicare coverage and supplemental insurance (such as Medigap) pay, on average, less than $2 per dose of Neulasta®, while the remaining 1% of prescriptions cost patients an average of $268 per dose.*


Medicare Advantage

62 percent

62% of prescriptions for Neulasta® for patients with Medicare Advantage insurance cost $5 or less per dose*

The remaining 38% of Neulasta® prescriptions cost patients an average of $748 per dose*

To understand what plan you fall into go to www.medicare.gov.

*These data are based on paid claims data from national data providers for the period 1/1/2018–12/31/2018. Your actual cost may vary depending on your dose, insurance coverage, and eligibility for support programs. Talk to your insurance provider for specific information about your prescription coverage.

I am on Medicaid

plus-img minus-img
99 percent

99% of prescriptions for Neulasta® for patients with Medicaid insurance cost $0 per dose*

The remaining 1% of Neulasta® prescriptions cost patients an average of $615 per dose*

*These data are based on paid claims data from national data providers for the period 1/1/2018–12/31/2018. Your actual cost may vary depending on your dose, insurance coverage, and eligibility for support programs. Talk to your insurance provider for specific information about your prescription coverage.

I am uninsured

plus-img minus-img
safety net foundation

The Amgen Safety Net Foundation supports uninsured patients and certain underinsured patients who do not have coverage for their Amgen medication and have a financial need. Qualifying uninsured patients must not be eligible for Medicaid, Medicare, or any other financial support options. The Amgen Safety Net Foundation may be able to provide Neulasta® at no cost to eligible patients.

Take me to Amgen Safety Net Foundation
aa360 logo

WE'RE HERE FOR YOU AND YOUR LOVED ONES

That's why we created Amgen Assist 360™. Assistance designed to support you throughout your treatment journey so you can focus on what's most important to you.

Monday through Friday — 9:00 am to 8:00 pm ET
resources icon

How we can help

SINGLE POINT OF CONTACT THROUGH OUR NURSE AMBASSADOR

Amgen nurse ambassadors provide a single point of contact who can help you find the resources that are most important to you.* Let our nurses provide personal support related to your financial and emotional wellness. Whatever you need, we’re here to help!

FINANCIAL SUPPORT OPTIONS FOR ANY INSURANCE TYPE

Whatever insurance you have—even if you have none—Amgen Assist 360™ can help you understand how your Amgen medicine may be covered, and refer you to programs that may be able to help you afford it.*

  • If you have commercial insurance and are eligible, the Amgen FIRST STEP™ co-pay program can help. Please see details below
  • If you have government insurance like Medicare, we can refer you to independent nonprofit patient assistance programs that may be able to help you afford the co-pay cost of your medicine*,§
  • If you are uninsured, the Amgen Safety Net Foundation, a nonprofit patient assistance program sponsored by Amgen, may be able to help you access Amgen medicines at no cost
REFERRALS TO RESOURCES FOR DAY-TO-DAY LIVING

We can refer you to independent nonprofit organizations that may provide you with community resources, one-on-one counseling services, and local support groups.

MEDICATION ANSWERS

Have questions about your Amgen medication? We can help you get the answers you need.

*Provided through independent nonprofit patient assistance programs; program eligibility is based on the nonprofit’s criteria. Amgen has no control over these programs and provides referrals as a courtesy only.

Patients should always talk to their healthcare provider about any medical decisions or concerns they have.

Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal, state, or government-funded healthcare program. Not valid where prohibited by law.

§Amgen Assist 360™ can refer patients to independent nonprofit patient assistance programs that may be able to help them afford the co-pay costs for their prescribed medicine.

3 ways to enroll

Download enrollment form
Submit your enrollment form for the Amgen Nurse Ambassador today!
phone icon

Call 1-888-4ASSIST
(1-888-427-7478)

Monday through Friday
9:00 am to 8:00 pm ET

fax icon

Fax 1-888-407-9787

Mail Icon

Mail PO Box 220354
Charlotte, NC 28222-9924

Important Safety Information

Do not take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.

Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
  • Have a sickle cell disorder
  • Have had severe skin reactions to acrylic adhesives
  • Are allergic to latex – The needle cap on the prefilled syringe contains dry natural rubber (derived from latex).
  • Have kidney problems
  • Are pregnant or plan to become pregnant. It is not known if Neulasta® may harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if Neulasta® passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible serious side effects of Neulasta®?
  • Spleen Rupture. Your spleen may become enlarged and can rupture while taking Neulasta®. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder tip area.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious Allergic Reactions. Neulasta® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate and sweating.
If you have an allergic reaction during the delivery of Neulasta®, remove the on-body injector for Neulasta® by grabbing the edge of the adhesive pad and peeling off the on-body injector. Get emergency medical help right away.
  • Sickle Cell Crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive Neulasta®.
  • Kidney injury (glomerulonephritis). Neulasta® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face or ankles, blood in your urine or dark colored urine, or you urinate less than usual.
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with Neulasta®.
  • Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with Neulasta®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with Neulasta®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.
  • Capillary Leak Syndrome. Neulasta® can cause fluid to leak from blood vessels into your body’s tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
    • Swelling or puffiness and are urinating less than usual
    • Trouble breathing
    • Swelling of your stomach area (abdomen) and feeling of fullness
    • Dizziness or feeling faint
    • A general feeling of tiredness
  • Myelodysplastic syndrome and acute myeloid leukemia. If you have breast cancer or lung cancer, when Neulasta® is used with chemotherapy and radiation therapy, or with radiation therapy alone, you may have an increased risk of developing a precancerous blood condition called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukemia (AML). Symptoms may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop these symptoms during treatment with Neulasta®.
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received Neulasta®. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effect of Neulasta® is pain in your bones and in your arms and legs.

These are not all the possible side effects of Neulasta®. Call your healthcare provider for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.

Please see Neulasta® Patient Information.

Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.

Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe co-packaged with the on-body injector (OBI) for Neulasta® (Neulasta® Onpro® kit).

Important Safety Information
Do not take take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.
Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
• Have a sickle cell disorder